Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial

Psilocybin

Breaking Taboos: Rabbi Leads Research On Psychedelics And Jewish Identity
Breaking Taboos: Rabbi Leads Research On Psychedelics And Jewish Identity
Sexual Health: Psychedelics Found To Enhance Function In Imperial College Study
Sexual Health: Psychedelics Found To Enhance Function In Imperial College Study
Portland Launches Nation's First Psilocybin Service Center Combining Mindfulness Practices
Portland Launches Nation's First Psilocybin Service Center Combining Mindfulness Practices
Sexual Health: Psychedelics Found To Enhance Function In Imperial College Study
Sexual Health: Psychedelics Found To Enhance Function In Imperial College Study
Portland Launches Nation's First Psilocybin Service Center Combining Mindfulness Practices
Portland Launches Nation's First Psilocybin Service Center Combining Mindfulness Practices
TV News Anchor Kendis Gibson Opens Up About Mental Health Struggles And Psychedelic Therapy In New Memoir
TV News Anchor Kendis Gibson Opens Up About Mental Health Struggles And Psychedelic Therapy In New Memoir
Kelly Slater Talks Psychedelics: Healing Trauma And Unlocking Potential
Kelly Slater Talks Psychedelics: Healing Trauma And Unlocking Potential

Psilocybin Recent News

Georgia Lawmakers Take First Steps Toward Psychedelic-Assisted Therapy For Veterans
Georgia Lawmakers Take First Steps Toward Psychedelic-Assisted Therapy For Veterans
Georgia lawmakers propose $5M for psychedelic research to treat veterans' PTSD, signaling growing acceptance of alternative mental health therapies.
Healthcare Workers Back Psychedelics But Lack Crucial Knowledge, Study Finds
Healthcare Workers Back Psychedelics But Lack Crucial Knowledge, Study Finds
A new study shows U.S. healthcare professionals support psychedelic therapies but face significant knowledge gaps, underscoring a need for formal training.
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
Psychedelic Mushrooms Market Poised For $3.3 Billion Surge By 2031
Psychedelic Mushrooms Market Poised For $3.3 Billion Surge By 2031
Psychedelic mushrooms market to reach $3.3 billion by 2031, due to rising demand, regulatory changes & growing psilocybin acceptance.
Pro Golfers Turn To Psychedelics For Focus Boost And Anxiety Relief
Pro Golfers Turn To Psychedelics For Focus Boost And Anxiety Relief
Pro golfers are using psychedelics like psilocybin and DMT to sharpen mental performance, signaling a new trend in sports wellness.
Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health
Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health
Joe Rogan and Elon Musk discuss the pharma industry's history of prioritizing profits over health, sparking debate on drug safety and ethics.
Psychoanalysis Meets LSD: Argentina's Lost 1950s Era Of Psychedelic Therapy
Psychoanalysis Meets LSD: Argentina's Lost 1950s Era Of Psychedelic Therapy
Explore Argentina's golden era of psychedelic therapy (1957-1967), where LSD and psychoanalysis merged for mental health treatments.
Magic Mushroom Strains: Is There Really A Difference?
Magic Mushroom Strains: Is There Really A Difference?
New research suggests magic mushroom strains are more alike than different. Focus on cultivation techniques, not strain names, to enhance potency and effects.
Massachusetts Veterans Advocate For Psilocybin Legalization: Will Voters Support Them?
Massachusetts Veterans Advocate For Psilocybin Legalization: Will Voters Support Them?
Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes
Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes
Over 5 million Americans with depression could be eligible for psilocybin-assisted therapy if FDA-approved, signaling vast market potential.
Missouri Allocates $5M For Psilocybin Research To Treat Opioid Addiction
Missouri Allocates $5M For Psilocybin Research To Treat Opioid Addiction
Missouri dedicates $5M from its opioid settlement fund to psilocybin research for treating opioid addiction, seeking expert input on this project.
Michigan Bill Could Legalize Psychedelic Mushrooms For PTSD Treatment
Michigan Bill Could Legalize Psychedelic Mushrooms For PTSD Treatment
Michigan introduces a bill to legalize psychedelic mushrooms for PTSD treatment, allowing adults to possess up to two ounces for personal use
DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling
DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling
The DEA increases production quotas for psychedelics like psilocybin and ibogaine, while marijuana quotas remain stable ahead of a possible rescheduling decision.
Psilocybin Found To Be As Effective As Lexapro In Treating Depression, Researchers Say
Psilocybin Found To Be As Effective As Lexapro In Treating Depression, Researchers Say
Psilocybin rivals antidepressants in treating depression while offering long-term well-being benefits, according to a new study.
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships.
Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care
Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care
Psyence Biomed initiates a Phase IIb psilocybin trial in Australia to explore its potential as a treatment for Adjustment Disorder.
Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects
Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects
Psilera's trip-free psilocybin drug PSIL-006 clears key safety milestone, potentially offering a breakthrough treatment for frontotemporal dementia.
Athletes Embrace Psychedelic Therapy For Concussion Symptoms, More Than One-Third Say It Helps
Athletes Embrace Psychedelic Therapy For Concussion Symptoms, More Than One-Third Say It Helps
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved